Slide 1: Elevating the World’s Wellbeing – Half one 2022
Elevating the World’s Wellbeing Half one 2022 (1 January 2022 – 30 June 2022) Webcast presentation | August 25th 10:00 CET Q2
Slide 2: Forward-looking statement
Forward-looking statement This presentation contains certain forward-looking statements and opinions. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for example, contain wording such as “beli
Slide 3: Agenda
Agenda Q2 in short Business update Financial results Strategy and outlook Q&A Henrik Molin CEO & co-founder Charlotte Goodwin CFO 3
Slide 4: Q2 in short
“+b Physitrack
Slide 5: Continuing to be in line with mid term targets
62% 31% 40% Continuing to be in line Adjusted EBITDA Q2 YTD 2022 Q2 YTD 2022 YTD increased to with mid term targets revenue growth proforma revenue growth €1.7m Acquisition integration Virtual Wellness Business Line Lifecare Technology Business Line - Integration of Access ecosystem into Champion -
Slide 6: Business updates
Business updates “+b Physitrack
Slide 7: What we do
What we do Physitrack PLC, founded in 2012, is a global B2B digital healthcare provider, focused on providing technology to Care Providers and providing virtual-first Wellness solutions to Corporates. Elevating the world’s wellbeing, the company has two business lines: Lifecare Technology Virtual We
Slide 8: Current state of play
Current state of play Revenue evolution EUR 12.2m (EURm) Wellness EUR 3.4m Lifecare Physitrack was born out of Technology Lifecare a desire to create a more EUR 5.3m Technology effective way to prescribe 89% exercise programs, as well Organic revenue EUR 8.8m as improve patient CAGR outcomes and red
Slide 9: The world leader in Lifecare technology
The world leader in Lifecare technology. Supporting the patient journey every step of the way with a uniquely comprehensive solution. Continuing Education Courses for Physiotherapists and Occupational therapists certification. Subscription that enables professional certification in 47 US states. A t
Slide 10: Lifecare Technology enhancements
Lifecare Technology enhancements 10% growth in subscription license numbers within our Lifecare Technology businesses PT Courses subscription model and high profile recruitments • Physitrack's e-learning provider PT Courses launched a new subscription product for 53,000 online courses in June 2022.
Slide 11: We have a massive market opportunity ahead of us
We have a massive market Opportunity ahead of us OUR CURRENT MARKET 2026 2019 $84B +14.8% CAGR $222B Source: F&F Research 11
Slide 12: One platform. All areas of Wellbeing.
One platform. All areas of Wellbeing. Empowering employee wellbeing through data, insight and action. PREVENTION & PREVENTION & POST-ACUTE, ANALYSIS & WELLNESS (PHYSICAL) WELLNESS POST-OP, CHRONIC FOLLOW-UP & ASSESSMENT ANALYSIS (EMOTIONAL) CARE PROVISION Testing and assessment Technology-led exerci
Slide 13: Our Wellness Brand
How to capture the opportunity? Our Wellness Brand Following review of our Wellness portfolio, the option of building a new brand and existing brand review we feel unifying under the Champion Health brand to be the best outcome for the group; A flexible all-encompassing Wellness brand Substantial si
Slide 14: Champion Health - Physiotherapy
Champion Health- Physiotherapy The Musculoskeletal pathways launched in Champion are the first step of the integration journey of the Access ecosystem, available at a subscription fee to corporate customers in key markets. An estimated 9.5m working days were lost due to work related MSK, costing UK
Slide 15: Nightingale partnership for biometric-led coaching
Nightingale partnership for biometric-led coaching During the quarter the Wellness division joined forces with Nightingale Health, a frontrunner in preventative health The new partnership will allow users of Physitrack’s Wellness offering in certain geographies to access biometric testing through at
Slide 16: Financial Results
Financial Results “+b Physitrack
Slide 17: Q2 Financial Highlights
Q2 Financial Highlights 6 month revenue Churn 62% -% €5.6m (Q2 2021: €3.5m) 1.3% (Q2 2021: 1.8%) 5pp Operating cashflow 6 month proforma 31% 16% revenue growth €0.3m (Q2 2021: €0.6m) 50% 6 month adjusted EBITDA 6 month adjusted EBITDA margin 40% €1.7m (Q2 2021: €1.2m) 29% (2021: 34%) 5pp 17
Slide 18: Maintaining revenue growth
Maintaining revenue growth In-line with medium term growth targets Group Revenue Lifecare Technology revenue growth Virtual Wellness revenue growth 3.5 2.5 2.5 31% 3.0 27% 2.0 2.0 2.5 62% Euro Million Euro Million Euro Million 1.5 2.0 1.5 1.5 1.0 1.0 44% 1.0 0.5 0.5 0.5 - - - Q1 2021 Q2 2021 Q3 2021
Slide 19: EBITDA – Stable growth excluding non-recurring costs
EBITDA Stable growth excluding non-recurring costs 2.0 3.0 2.5 1.5 40% 0.8 2.0 €1.2M 40% €’million 1.0 €’million 1.5 0.7 €1.2M €1.7M 0.9 1.0 0.5 €1.4M ADJUSTED ADJUSTED 0.6 EBITDA Margin EBITDA Margin 34% 29% €0.5M 0.5 0.7 0.5 - (€0.2M) - 2021 ADJ EBITDA 2022 ADJ EBITDA 6 MONTHS Adjusting 6 MONTHS 6
Slide 20: Cashflow
CASHFLOW Cash reinvested in investing activities 16.0 (0.4) (0.0) 14.0 1.7 (2.1) 12.0 10.0 €’million (7.4) 8.0 13.3 6.0 (0.9) 4.0 (0.1) 2.0 4.1 - 1 Jan 2022 Opening Net Adjusted EBITDA Working capital Interest expense Purchase of intangibles Acqui stions net of cash M&A costs Fx 30 June 2022 Closing
Slide 21: Balance Sheet
Balance Sheet Net assets position strengthened from goodwill and intangibles recognized on acquisitions 30 June 2022 31 December 2021 Euros ‘000 Goodwill, intangibles and PPE 37,575 17,221 Cash and cash equivalents 4,118 13,325 Borrowings - (1) Trade and other receivables 2,762 1,666 Inventory 64 67
Slide 22: Strategy and outlook
Strategy and outlook “+b Physitrack
Slide 23: Executing a well-defined growth plan combining organic and inorganic initiatives
Executing a well-defined growth plan combining organic and inorganic initiatives Planning to build a global powerhouse in the remote physical care space through well-defined, tangible organic and inorganic growth objectives 3 M&A initiative 2 Continue strong M&A integration Organic growth levers to
Slide 24: Financial goals – What we aim for
Financial goals – What we aim for Top-line growth Profit margins Value creation/distribution Physitrack aims to achieve annual Physitrack targets an EBITDA margin of Physitrack aims to reinvest profits and organic sales growth exceeding 30% in 40-45% in the medium term, with cash flows in organic gr
Slide 25: Physitrack
“+b Physitrack